Dr. Mark Kasevich's research interests include:

• Development of quantum-optimal imaging protocols and instruments, including high speed fluorescence lifetime microscopy;
• Multipass electron microscopy, and multipass Raman microscopy;
• Quantum sensing and networks, including development of networked entangled state atomic clocks and interferometers.

The Mercola laboratory is focused on developing new therapies for cardiovascular disease: their research combines in vitro disease models using cardiovascular cells generated from induced pluripotent stem cells with high throughput screening to define disease mechanisms, identify drug targets and develop drug leads.

Dr. Pegram’s current research efforts include a continued focus on the cancer-associated gene that encodes HER2 and developing new ways to target cancer cells expressing this protein.

The long-term goal of the Schnitzer lab's research is to advance experimental paradigms for understanding normal cognitive and disease processes at the level of neural circuits, with emphasis on learning and memory processes.